More trouble for baby products maker, Johnson and Johnson. Indian top drug regulation body has ordered scrutiny over Johnson and Johnson products. Last month, J&J had lost a lawsuit in United States after a 62 year old woman died of ovarian cancer, reportedly caused due to the prolonged us of Johnson’s baby talc.
The drug regulator in India has ordered sample testing of J&J products across the country.
“The brands is under scrutiny at our end and we have ordered sample testing across India,” GN Singh, Drug Controller General of India told HT. “Depending on preliminary outcomes we will extend the probe.” Further, government will inspect J&J factories and manufacturing units in India, in case of non-compliance found.
Maharashtra Food and Drug Administration (FDA) has also sent samples of products for lab testing as a precautionary measure. FDA has also discussed their concerns with company officials. “We are committed to patient safety their rights and well beings. Understanding the concern of mothers on these issues, I shall do my best,” Singh said.
Concerns are pouring in across globe including India where users are blaming J&J of betraying their trust via social media channels.
While company’s comments for the probe ordered are awaited, J&J had issued a standard statement across globe, saying, “The recent jury outcome goes against decades of sound science proving the safety of talc as a cosmetic ingredient in multiple products.. we strongly disagree with the outcome.”
J&J, the world’s biggest health care products maker, last month, was found liable for fraud, negligence and conspiracy in a civil suit relating to the death of the 62 year old. An American Jury ordered the company to pay $72 million of damages to the family of the woman.
J&J claimed in its statement that the products are safe to use. “Our confidence in using talc reflects more than 30 years of research by independent scientists, review boards and global authorities, which have concluded that talc can be used safely in personal care products.”